SCHEMBL22842218

SCHEMBL22842218

CC(C)(CCOC(C)(C)CCC(=O)O)NC(=O)[C@H](CSSC(C)(C)C)NC(=O)[C@H](CN)N1C(=O)C=CC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22841401 0.91 — —
SCHEMBL22841483 0.77 AKT1 (0.31) —
SCHEMBL22241568 0.77 AKT1 (0.31) —
SCHEMBL16665959 0.77 — —
SCHEMBL16665955 0.77 — —
SCHEMBL18180519 0.77 TLR2 (0.33) —
SCHEMBL22241569 0.77 — —
SCHEMBL22241565 0.73 — —
SCHEMBL27315897 0.66 PTGS1 (0.40) —
SCHEMBL16665817 0.66 SIRT6 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3756663-A1 PEGYLATED DRUG-LINKERS FOR IMPROVED LIGAND-DRUG CONJUGATE PHARMACOKINETICS Seagen Inc. (US) 2020-12-30 — — EP disclosed
Send feedback